The majority of tRCC samples showed increased expression of PPARGC1A (0/3 normal, 0/3 ccRCC, and 7/8 in tRCC samples; Fig. 3f). The gene discussed is PPARGC1A; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.